BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jurcau A, Jurcau MC. Therapeutic Strategies in Huntington’s Disease: From Genetic Defect to Gene Therapy. Biomedicines 2022;10:1895. [DOI: 10.3390/biomedicines10081895] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Jurcau A, Jurcau CM. Mitochondria in Huntington's disease: implications in pathogenesis and mitochondrial-targeted therapeutic strategies. Neural Regen Res 2023;18:1472-7. [PMID: 36571344 DOI: 10.4103/1673-5374.360289] [Reference Citation Analysis]
2 Andronie-cioara FL, Ardelean AI, Nistor-cseppento CD, Jurcau A, Jurcau MC, Pascalau N, Marcu F. Molecular Mechanisms of Neuroinflammation in Aging and Alzheimer’s Disease Progression. IJMS 2023;24:1869. [DOI: 10.3390/ijms24031869] [Reference Citation Analysis]
3 Wu J, Möhle L, Brüning T, Eiriz I, Rafehi M, Stefan K, Stefan SM, Pahnke J. A Novel Huntington's Disease Assessment Platform to Support Future Drug Discovery and Development. Int J Mol Sci 2022;23. [PMID: 36499090 DOI: 10.3390/ijms232314763] [Reference Citation Analysis]
4 Siafaka PI, Okur ME, Erim PD, Çağlar EŞ, Özgenç E, Gündoğdu E, Köprülü REP, Karantas ID, Üstündağ Okur N. Protein and Gene Delivery Systems for Neurodegenerative Disorders: Where Do We Stand Today? Pharmaceutics 2022;14:2425. [DOI: 10.3390/pharmaceutics14112425] [Reference Citation Analysis]